Kilitch Drugs (India) Ltd : Pharmaceutical Formulations

- Core Business: Engaged in manufacturing and marketing pharmaceutical formulations in various dosage forms. - Global Presence: Strong market presence in Africa, Asia, CIS, and Latin America. Business Expansion and Operations - New Project: Setting up a Green Field Pharmaceutical Project in Khopoli, Maharashtra, India. - Product Range: Producing Oral Tablets, Liquid Injectable Vials, Ophthalmic Drops, and Nasal Drops. - Operational Highlights: - Launched Cephalosporin facility in Ethiopia, boosting private market growth. - Secured a USD 9.13 million government supply tender in Ethiopia. - Increased capacity for Ophthalmic products at Mumbai plant. - High customer retention with clients like Intas, Mankind, and Indoco Remedies. Ethiopia Market Expansion - Ethiopian Operations: - Received significant USD 9.13 million government order, holding 70% market share. - INR 50 crores invested in facility with income tax benefits and local manufacturing advantages. Financial Targets and Outlook - Financial Strategy: - Utilizing INR 30 crores as working capital, targeting EBITDA positivity with government tender. - Anticipates 25%-30% year-on-year growth in FY '25, focusing on new product development. Learning Outcome: Understanding this pharmaceutical company's expansive operations, strategic initiatives in global markets, financial targets, and operational updates highlights the complexities and opportunities in the pharmaceutical industry, emphasizing growth through new projects, market expansions, and financial strategies.